These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2080936)
1. A new comprehensive technique of catheterisation, blood sampling, sample preparation and sample analysis by means of high-pressure liquid chromatography for pharmacokinetic studies with estradiol-linked nitrosoureas and their metabolites. Betsch B; Berger MR; Spiegelhalder B Arzneimittelforschung; 1990 Sep; 40(9):1022-5. PubMed ID: 2080936 [TBL] [Abstract][Full Text] [Related]
2. New estradiol-linked nitrosoureas: can the pharmacokinetic properties help to explain the pharmacodynamic activities? Betsch B; Berger MR; Spiegelhalder B; Eisenbrand G; Schmähl D Eur J Cancer Clin Oncol; 1989 Jan; 25(1):105-11. PubMed ID: 2920758 [TBL] [Abstract][Full Text] [Related]
3. An oestradiol-linked nitrosourea and site-directed chemotherapy in mammary carcinoma. Betsch B; Berger MR; Spiegelhalder B; Schmähl D; Eisenbrand G Eur J Cancer; 1990; 26(8):895-8. PubMed ID: 2145934 [TBL] [Abstract][Full Text] [Related]
4. Development of more selective anti-cancer nitrosoureas. Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304 [TBL] [Abstract][Full Text] [Related]
5. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia. Zeller WJ; Schreiber J; Petru E; Eisenbrand G Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608 [TBL] [Abstract][Full Text] [Related]
6. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison]. Petru E; Berger MR; Zeller WJ; Kaufmann M Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice. Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705 [TBL] [Abstract][Full Text] [Related]
9. Direct injection of whole blood for liquid chromatography/tandem mass spectrometry analysis to support single-rodent pharmacokinetic studies. Ingelse BA; Vogel G; Botterblom M; Nanninga D; Ooms B Rapid Commun Mass Spectrom; 2008; 22(6):834-40. PubMed ID: 18286667 [TBL] [Abstract][Full Text] [Related]
10. Modulation of cytosolic sexual steroid receptors in autochthonous methylnitrosourea-induced rat mammary carcinoma following application of 2-chloroethylnitrosocarbamoyl-L-alanine linked to oestradiol or dihydrotestosterone. Corr R; Berger MR; Betsch B; Floride JA; Brix HP; Schmähl D Br J Cancer; 1990 Jul; 62(1):42-7. PubMed ID: 2390481 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man. Petru E; Berger MR; Zeller WJ; Kaufmann M Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1027-32. PubMed ID: 3409940 [TBL] [Abstract][Full Text] [Related]
12. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry. Przybylski M Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419 [TBL] [Abstract][Full Text] [Related]
13. [Chemotherapeutic characterization of new nitrosourea compounds]. Zeller WJ; Berger MR; Eisenbrand G; Petru E Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433 [TBL] [Abstract][Full Text] [Related]
14. Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials. Osman S; Luthra SK; Brady F; Hume SP; Brown G; Harte RJ; Matthews JC; Denny WA; Baguley BC; Jones T; Price PM Cancer Res; 1997 Jun; 57(11):2172-80. PubMed ID: 9187117 [TBL] [Abstract][Full Text] [Related]
15. Novel steroid-linked conjugates of 17 beta-[N-[N'-(2-chloroethyl)-N'-nitroso]carbamoyl]amino acids and their antineoplastic activity against Noble Nb prostate carcinoma model in rats. Tang W; Schneider MR; Eisenbrand G Anticancer Drug Des; 1998 Oct; 13(7):815-24. PubMed ID: 9807164 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic model and distribution pattern of new sexual-steroid-hormone-linked anticancer agents. Betsch B J Cancer Res Clin Oncol; 1990; 116(5):467-9. PubMed ID: 2229135 [TBL] [Abstract][Full Text] [Related]
17. Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions. Berger MR; Floride J; Schmähl D; Schreiber J; Eisenbrand G Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1179-91. PubMed ID: 3816911 [TBL] [Abstract][Full Text] [Related]
18. Rapid and sensitive ultra-high-pressure liquid chromatography-tandem mass spectrometry analysis of the novel anticancer agent PR-104 and its major metabolites in human plasma: Application to a pharmacokinetic study. Gu Y; Wilson WR J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3181-6. PubMed ID: 19709934 [TBL] [Abstract][Full Text] [Related]
19. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic studies of chloroethylnitrosocarbamoyl-amino acid derivatives in vivo and in vitro. Matthew AM; Bibby MC; Eisenbrand G Anticancer Res; 1993; 13(1):81-6. PubMed ID: 8476230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]